Preventive and therapeutic effects of a super-multivalent sialylated filamentous bacteriophage against the influenza virus
- 6 August 2024
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 312, 122736
Abstract
No abstract availableKeywords
Funding Information
- Korea Ministry of Education (2017R1A6A1A03015642)
- Korea Ministry of Science and ICT (2023R1A2C2006548)
- National Research Foundation of Korea
- Korea Human Resource Development Institute for Health and Welfare
- Korea Ministry of Health and Welfare (HI22C060700)
This publication has 53 references indexed in Scilit:
- A Dynamic, Supramolecular View on the Multivalent Interaction between Influenza Virus and Host CellSmall, 2021
- Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracleJournal of Medical Virology, 2020
- Multivalent Sialosides: A Tool to Explore the Role of Sialic Acids in Biological ProcessesChemistry – An Asian Journal, 2019
- Phage‐Enabled Nanomedicine: From Probes to Therapeutics in Precision MedicineAngewandte Chemie International Edition, 2016
- Role of receptor binding specificity in influenza A virus transmission and pathogenesisThe EMBO Journal, 2014
- Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United StatesJAMA, 2009
- Emergence of amantadine-resistant influenza A viruses: epidemiological studyJournal of Infection and Chemotherapy, 2003
- Large-scale production of CMP-NeuAc and sialylated oligosaccharides through bacterial couplingApplied Microbiology and Biotechnology, 2000
- Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A virusesVirology, 1991
- Synthetic polymeric sialoside inhibitors of influenza virus receptor‐binding activityFEBS Letters, 1990